血清CA19-9联合外周血NLR、PLR、MLR、SII对肝外胆管癌的诊断价值
Diagnostic Value of Serum CA19-9 Combined with Peripheral Blood NLR, PLR, MLR and SII in Extrahepatic Cholangiocarcinoma
摘要: 目的:探讨CA19-9、中性粒细胞淋巴细胞比率(NLR)、血小板淋巴细胞比率(PLR)、单核细胞淋巴细胞比率(MLR)和全身免疫炎症指数(SII)在肝外胆管癌(ECC)中的诊断价值。方法:选取2012年1月~2021年9月青岛市市立医院收治的ECC患者150例作为ECC组及150例健康体检者作为对照组,对其CA19-9、NLR、PLR、MLR和SII进行检测分析。采用受试者工作特征(ROC)曲线分析各指标单独和联合检测诊断ECC的效能。结果:ECC组CA19-9、NLR、PLR、MLR、SII的水平均高于对照组(P < 0.05)。ROC曲线分析显示,CA19-9、NLR、PLR、MLR、SII诊断ECC所对应的AUC值分别为0.899、0.869、0.857、0.796、0.884,四项炎症指标诊断敏感性分别为68.70%、74.00%、72.70%、79.30%,特异性分别为94.00%、84.00%、76.00%、87.30%,CA19-9联合四项炎症指标进行诊断的AUC值为0.975,敏感性和特异性为92.00%和96.70%。结论:CA19-9、NLR、PLR、MLR、SII在ECC患者中升高,对于ECC的诊断有一定价值,联合诊断相比于单个指标具有更高的诊断效能。
Abstract: Objective: To investigate the diagnostic value of CA19-9 combined with neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), monocyte lymphocyte ratio (MLR) and systemic immune inflammation index (SII) in extrahepatic cholangiocarcinoma (ECC). Methods: 150 patients with ECC treated in Qingdao Municipal Hospital from January 2012 to September 2021 were selected as the cholangiocarcinoma group and 150 healthy patients as the control group. CA19-9, neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), monocyte lymphocyte ratio (MLR) and systemic immune inflammation index (SII) were detected and analyzed. The diagnostic efficiency of single and combined parameters for ECC was evaluated by the ROC (receiver operating characteristic) curve. Results: The levels of CA19-9, NLR, PLR, MLR and SII in ECC group were higher than those in control group (P < 0.05). The ROC curve analysis showed that the areas under the ROC curve corresponding to the diagnosis of ECC by CA19-9, NLR, PLR, MLR and SII were 0.899, 0.869, 0.857, 0.796 and 0.884 respectively. The diagnostic sensitivity of NLR, PLR, MLR and SII was 68.70%, 74.00%, 72.70% and 79.30% respectively, and the specificity was 94.00%, 84.00%, 76.00% and 87.30% respectively. The area under the curve of CA19-9 combined with NLR, PLR, MLR and SII was 0.975, and the sensitivity and specificity were 92.00% and 96.70%. Conclusion: CA19-9, NLR, PLR, MLR and SII are increased in patients with ECC, which is of certain value for the diagnosis of ECC. Combined diagnosis has higher diagnostic efficiency than single index.
文章引用:徐豪, 马晓莹, 许琳. 血清CA19-9联合外周血NLR、PLR、MLR、SII对肝外胆管癌的诊断价值[J]. 临床医学进展, 2021, 11(11): 5132-5137. https://doi.org/10.12677/ACM.2021.1111757

参考文献

[1] Rizvi, S., Khan, S.A., Hallemeier, C.L., Kelley, R.K. and Gores, G.J. (2018) Cholangiocarcinoma—Evolving Concepts and Therapeutic Strategies. Nature Reviews Clinical Oncology, 15, 95-111. [Google Scholar] [CrossRef] [PubMed]
[2] 陶连元, 何小东, 高飞, 王磊, 张锋良, 龙志华, 等. 肝外胆管癌的临床病理与预后分析[J]. 肝胆外科杂志, 2011, 19(4): 251-253.
[3] Wang, J.K., Hu, H.J., Shrestha, A., Ma, W.-J., Yang, Q., Liu, F., et al. (2017) Can Preoperative and Postoperative CA19-9 Levels Predict Survival and early Recurrence in Patients with Resectable Hilar Cholangiocarcinoma? Oncotarget, 8, 45335-45344. [Google Scholar] [CrossRef] [PubMed]
[4] Zhong, J.H., Huang, D.H. and Chen, Z.Y. (2017) Prognostic Role of Systemic Immune-Inflammation Index in Solid Tumors: A Systematic Review and Meta-Analysis. Oncotarget, 8, 75381-75388. [Google Scholar] [CrossRef] [PubMed]
[5] Akgul, O., Cetinkaya, E., Yalaza, M., Özden, S. and Tez, M. (2017) Prognostic Efficacy of Inflammation-Based Markers in Patients with Curative Colorectal Cancer Resection. World Journal of Gastrointestinal Oncology, 9, 300-307. [Google Scholar] [CrossRef] [PubMed]
[6] Choi, Y., Kim, J.W., Nam, K.H., Han, S.-H., Kim, J.-W., Ahn, S.-H., et al. (2017) Systemic Inflammation Is Associated with the Density of Immune Cells in the Tumor Microenvironment of Gastric Cancer. Gastric Cancer, 20, 602-611. [Google Scholar] [CrossRef] [PubMed]
[7] Dirkx, A.E.M., Egbrink, M., Wagstaff, J. and Griffioen, A.W. (2006) Monocyte/Macrophage Infiltration in Tumors: Modulators of Angiogenesis. Journal of Leukocyte Biology, 80, 1183-1196. [Google Scholar] [CrossRef] [PubMed]
[8] Lu, Y., Xin, D. and Wang, F. (2019) Predictive Significance of Preoperative Systemic Immune-Inflammation Index Determination in Postoperative Liver Metastasis of Colorectal Cancer. Oncotargets and Therapy, 12, 7791-7799. [Google Scholar] [CrossRef
[9] Macias, R.I. R., Kornek, M., Rodrigues, P.M., Paiva, N.A., Castro, R.E., Urban, S., et al. (2019) Diagnostic and Prognostic Biomarkers in Cholangiocarcinoma. Liver International, 39, 108-122. [Google Scholar] [CrossRef] [PubMed]
[10] Diakos, C.I., Charles, K.A., McMillan, D.C. and Clarke, S.J. (2014) Cancer-Related Inflammation and Treatment Effectiveness. Lancet Oncology, 15, E493-E503. [Google Scholar] [CrossRef
[11] Mantovani, A. (2009) CANCER Inflaming Metastasis. Nature, 457, 36-37. [Google Scholar] [CrossRef] [PubMed]
[12] Szebeni, G.J., Vizler, C., Kitajka, K. and Puskas, L.G. (2017) Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters. Mediators of Inflammation, 2017, Article ID: 9294018. [Google Scholar] [CrossRef] [PubMed]
[13] Yilmaz, A., Mirili, C., Bilici, M. and Tekin, S.B. (2019) A Novel Predictor in Patients with Gastrointestinal Stromal Tumors: Systemic Immune-Inflammation Index (SII). Journal of Buon, 24, 2127-2135.
[14] Hoshimoto, S., Hishinuma, S., Shirakawa, H., Tomikawa, M., Ozawa, I. and Ogata, Y. (2019) Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma. Oncology, 96, 290-298. [Google Scholar] [CrossRef] [PubMed]
[15] Kumamoto, Y., Kaizu, T., Tajima, H., Nishizawa, N., Ei, S., Igarashi, K., et al. (2018) Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Morbidity in Patients with Distal Cholangiocarcinoma. Molecular and Clinical Oncology, 9, 362-368. [Google Scholar] [CrossRef] [PubMed]
[16] Terasaki, F., Sugiura, T., Okamura, Y., Ito, T., Yamamoto, Y., Ashida, R., et al. (2021) Systemic Immune-Inflammation Index as a Prognostic Marker for Distal Cholangiocarcinoma. Surgery Today, 51, 1602-1609. [Google Scholar] [CrossRef] [PubMed]